Par avoids pay-for-delay suit after court accepts payment was ‘fair’

A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Generics

Glenmark becomes fifth generic to be charged with US antitrust violations

2 July 2020 Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute

7 January 2021 Pharmaceutical companies MSD and Glenmark have argued that the class certification of wholesale buyers of cholesterol drug Zetia should be reversed because the circumstances of the class members do not justify an award of class status.

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Generics

Glenmark becomes fifth generic to be charged with US antitrust violations

2 July 2020 Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Generics

Glenmark becomes fifth generic to be charged with US antitrust violations

2 July 2020 Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute